JULIE WIDMAR: Open Payments
NPI 1669148912 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 6 payments from 3 companies in 2025. Trend: 2023 $5,027 · 2024 $5,418 · 2025 $392
Food & beverage: $242Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 3 | $205 |
| Novartis Pharmaceuticals Corporation | 2 | $152 |
| GENZYME CORPORATION | 1 | $35 |
Products named: TYSABRI, KESIMPTA, VUMERITY.
Industry payments across OH — which companies pay providers there.
